Bayer Will Use Stratagene s QPCR Platform to Develop Instrument for IVD Market | GenomeWeb

NEW YORK, March 14 (GenomeWeb News) - Stratagene said today that Bayer Healthcare's diagnostics division will purchase minimally customized versions of Stratagene's Mx3005P QPCR instrument for use in a new platform Bayer is developing for molecular diagnostic tests.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.